ProKidney Corp. (PROK) Financials
PROK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 249.0 million | 26.2 million |
| March 31, 2026 | 292.8 million | 29.7 million |
| Dec. 31, 2025 | 335.6 million | 34.8 million |
| Sept. 30, 2025 | 351.6 million | 33.3 million |
PROK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -44.2 million | 5.6 million |
| March 31, 2026 | -45.5 million | 4.9 million |
| Dec. 31, 2025 | -38.3 million | 5.7 million |
| Sept. 30, 2025 | -31.8 million | 6.7 million |
PROK Net Income
No data available :(
PROK Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 181.6 million | - | 3.5 million |
| March 31, 2026 | 224.9 million | - | 3.8 million |
| Dec. 31, 2025 | 270.0 million | - | 4.0 million |
| Sept. 30, 2025 | 271.7 million | - | 4.2 million |
PROK Shares Outstanding
PROK Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 3.8 million | 36.1 million | 12.4 million | - |
| March 31, 2026 | 3.8 million | 33.8 million | 11.3 million | - |
| Dec. 31, 2025 | 5.8 million | 34.2 million | 6.3 million | - |
| Sept. 30, 2025 | 5.2 million | 26.8 million | 11.9 million | - |
PROK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 150000 | - |
| March 31, 2026 | 226000 | 1.4 million |
| Dec. 31, 2025 | 225000 | 1.4 million |
| Sept. 30, 2025 | 217000 | 1.4 million |
PROK Revenue by Segment
Graph available only for paid members. Upgrade to see it.
PROK
Price: $1.44
52 week price:
Earnings Per Share: -0.55 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 558.9 million